Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Jazz Pharmaceuticals's JZP-815?
JZP-815 is a small molecule commercialized by Jazz Pharmaceuticals, with a leading Phase I program in Hematological Tumor. According to...
Data Insights
Risk adjusted net present value: What is the current valuation of Jazz Pharmaceuticals's JZP-815?
JZP-815 is a small molecule commercialized by Jazz Pharmaceuticals, with a leading Phase I program in Blood Cancer. According to...